5-Halo- or nitrate-substituted paclitaxels under study at Bristol-Myers Squibb July 1, 1999 No Comments
New compounds from Merck inhibit posttranslational farnesylation of proteins June 30, 1999 No Comments
FeRx's targeted carrier tested in doxorubicin delivery to liver cancer patients June 30, 1999 No Comments
RSS